H1B Report
Side-by-side comparison

INFOSYS LIMITED vs Teva Pharmaceuticals USA, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
INFOSYS LIMITED
TXRank #1FEIN 58-1760235
Entity B
Teva Pharmaceuticals USA, Inc.
NJRank #FEIN 22-1734359

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricINFOSYS LIMITEDTeva Pharmaceuticals USA, Inc.
Total filings205,263341
Certified %99.55%80.06%
Denied %0.21%0.88%
Withdrawn %0.20%6.16%
Cert-withdrawn %0.05%12.90%
Rank#1
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateTXNJ

Outcomes — INFOSYS LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.5%, Cert-withdrawn 0.0%, Withdrawn 0.2%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%

Outcomes — Teva Pharmaceuticals USA, Inc.

DOL case-status mix.

Outcome breakdown: Certified 80.1%, Cert-withdrawn 12.9%, Withdrawn 6.2%, Denied 0.9%
Outcome breakdown
OutcomeShare
Certified80.1%
Cert-withdrawn12.9%
Withdrawn6.2%
Denied0.9%
Certified80.1%
Cert-withdrawn12.9%
Withdrawn6.2%
Denied0.9%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

INFOSYS LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,164
FY20111,681
FY201214,701
FY201332,232
FY201423,749
FY201533,214
FY201625,335
FY201720,571
FY201811,569
FY201921,420
FY202016
FY202129
FY202222
FY20232,269
FY20245,943
FY20255,790
FY20264,558
Teva Pharmaceuticals USA, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201010
FY201110
FY201228
FY201311
FY201417
FY201534
FY201630
FY201751
FY201865
FY201940
FY20205
FY202113
FY20228
FY20232
FY20244
FY20257
FY20266

Top 5 occupations — INFOSYS LIMITED

Top 5 occupations — Teva Pharmaceuticals USA, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.